Ilypsa, Inc.

Ilypsa, Inc.

Ilypsa, Inc.

Overview
Date Founded

2003

Headquarters

One Amgen Center Drive,Thousand Oaks, CA 91320

Type of Company

Private

Industries

Biotechnology
Pharmaceuticals

Company Description

Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.

Executives & Employees

President & Chief Executive Officer

Paths to Ilypsa, Inc.
Potential Connections via
Relationship Science
You
Ilypsa, Inc.
Recent Transactions
Details Hidden

Amgen, Inc. purchases Ilypsa, Inc.

Transaction Advisors
Legal Advisor

Advised onAmgen, Inc. purchases Ilypsa, Inc.

Investment Advisor

Advised onAmgen, Inc. purchases Ilypsa, Inc.

Investors
Details Hidden

Co-Founder at Ardelyx, Inc.

Details Hidden

Chief Executive Officer & President at Tricida, Inc.

Details Hidden

Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ilypsa, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ilypsa, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ilypsa, Inc..